Thanks to you, "BIG Time for Baby" is making progress.

Intro text: 

Thanks to you, "BIG Time for Baby" is making progress, with already 262 women enrolled and 32 healthy babies born.

The trial, launched in 2014, is steadily enrolling patients, giving hope to thousands of women wishing to have a baby after breast cancer.

POSITIVE, the official scientific name of the study, was developed for all young breast cancer patients who face the disease before having addressed their family planning wishes. Women with breast cancer may not have time to wait until after 5 to 10 years of treatment before considering pregnancy. The 'BIG Time for Baby' trial expects to provide an answer to the question of whether women can interrupt their endocrine treatment to try to have a baby, without increasing the risk of cancer recurrence. 

At the end of June 2018, a halfway milestone was reached: 262 of 500 patients enrolled in the study, in more than 15 countries. Today there are already more than 32 healthy babies born.


This trial provides a unique opportunity to gather definitive research data about the safety of interrupting therapy to attempt pregnancy after breast cancer, something that is currently lacking.


Make breast cancer patients’ dream of having a baby come true